{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:30:17Z","timestamp":1786116617014,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202893"],"award-info":[{"award-number":["82202893"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01559-y","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:14:09Z","timestamp":1786014849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dedifferentiated Liposarcoma Presenting as Primary Diffuse Peritoneal Sarcomatosis: A Case Report and Literature Review"],"prefix":"10.1007","volume":"57","author":[{"given":"Jiongyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6055-8693","authenticated-orcid":false,"given":"Jinglei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"1","key":"1559_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1200\/JCO.2008.17.8871","volume":"27","author":"A Gronchi","year":"2009","unstructured":"Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27(1):24\u201330. https:\/\/doi.org\/10.1200\/JCO.2008.17.8871.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1559_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/CCO.0b013e32834796e6","volume":"23","author":"AM Crago","year":"2011","unstructured":"Crago AM, Singer S. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma. Curr Opin Oncol. 2011;23(4):373\u20138. https:\/\/doi.org\/10.1097\/CCO.0b013e32834796e6.","journal-title":"Curr Opin Oncol"},{"issue":"12","key":"1559_CR3","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1002\/cncr.21933","volume":"106","author":"E Fabre-Guillevin","year":"2006","unstructured":"Fabre-Guillevin E, Coindre JM, Somerhausen NS, et al. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas. Cancer. 2006;106(12):2725\u201333. https:\/\/doi.org\/10.1002\/cncr.21933.","journal-title":"Cancer"},{"issue":"1","key":"1559_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1200\/JCO.2008.18.0802","volume":"27","author":"S Bonvalot","year":"2009","unstructured":"Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27(1):31\u20137. https:\/\/doi.org\/10.1200\/JCO.2008.18.0802.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1559_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/PAS.0b013e3182417330","volume":"36","author":"K Thway","year":"2012","unstructured":"Thway K, Flora R, Shah C, et al. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Am J Surg Pathol. 2012;36(3):462\u20139. https:\/\/doi.org\/10.1097\/PAS.0b013e3182417330.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"1559_CR6","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.5858\/2006-130-1448-GOSTSR","volume":"130","author":"JM Coindre","year":"2006","unstructured":"Coindre JM. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med. 2006;130(10):1448\u201353. https:\/\/doi.org\/10.5858\/2006-130-1448-GOSTSR.","journal-title":"Arch Pathol Lab Med"},{"key":"1559_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijscr.2019.06.051","volume":"60","author":"M Cai","year":"2019","unstructured":"Cai M, Siew YS, Tan GHC, et al. Dedifferentiated liposarcoma with a rare presentation of disseminated intraperitoneal sarcomatosis: a case report. Int J Surg Case Rep. 2019;60:331\u20135. https:\/\/doi.org\/10.1016\/j.ijscr.2019.06.051.","journal-title":"Int J Surg Case Rep"},{"issue":"3","key":"1559_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4103\/ijc.IJC_1128_20","volume":"59","author":"MA Atram","year":"2022","unstructured":"Atram MA, Deshmukh A, Shivkumar VB, Gangane NM. Intraperitoneal dissemination of primary dedifferentiated liposarcoma of omentum simulating an ovarian cancer \u2014 a case report. Indian J Cancer. 2022;59(3):422\u20135. https:\/\/doi.org\/10.4103\/ijc.IJC_1128_20.","journal-title":"Indian J Cancer"},{"key":"1559_CR9","doi-asserted-by":"crossref","unstructured":"Yambe K, Nakagawa K, Yamamoto K, et al. Retroperitoneal Dedifferentiated Liposarcoma With Penetrating Abscess Formation Secondary to Ileal Invasion: A Case Report. Clin Case Rep. 2026;14(1):e71561. https:\/\/doi.org\/10.1002\/ccr3.71561","DOI":"10.1002\/ccr3.71561"},{"issue":"4","key":"1559_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrc3432","volume":"13","author":"E Kipps","year":"2013","unstructured":"Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13(4):273\u201382. https:\/\/doi.org\/10.1038\/nrc3432.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1559_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/01.sla.0000086542.11899.38","volume":"238","author":"S Singer","year":"2003","unstructured":"Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238(3):358\u201371. https:\/\/doi.org\/10.1097\/01.sla.0000086542.11899.38.","journal-title":"Ann Surg"},{"issue":"20","key":"1559_CR12","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737\u201343. https:\/\/doi.org\/10.1200\/JCO.2003.04.187.","journal-title":"J Clin Oncol"},{"key":"1559_CR13","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Casares FC, Mart\u00edn-Broto J, Valverde CM, et al. Ibero-American consensus for the management of peritoneal sarcomatosis: updated review and clinical recommendations. Cancers (Basel). 2024;16(15):2646. https:\/\/doi.org\/10.3390\/cancers16152646","DOI":"10.3390\/cancers16152646"},{"issue":"3","key":"1559_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ejso.2021.10.013","volume":"48","author":"LCK Wong","year":"2022","unstructured":"Wong LCK, Li Z, Fan Q, et al. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal sarcomatosis \u2014 a systematic review and meta-analysis. Eur J Surg Oncol. 2022;48(3):640\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2021.10.013.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"1559_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","volume":"15","author":"I Judson","year":"2014","unstructured":"Judson I, Verweij J, Gelderblom H, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15(4):415\u201323. https:\/\/doi.org\/10.1016\/S1470-2045(14)70063-4.","journal-title":"Lancet Oncol"},{"issue":"1\u20132","key":"1559_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14737140.2023.2290196","volume":"24","author":"JE Quiroz-Aldave","year":"2024","unstructured":"Quiroz-Aldave JE, et al. Ifosfamide-induced nephrotoxicity in oncological patients. Expert Rev Anticancer Ther. 2024;24(1\u20132):5\u201314. https:\/\/doi.org\/10.1080\/14737140.2023.2290196.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1559_CR17","doi-asserted-by":"crossref","unstructured":"Skinner R, Cotterill SJ, Stevens MC. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. J Clin Oncol. 1993;11(1):173\u2013190. https:\/\/doi.org\/10.1200\/JCO.1993.11.1.173","DOI":"10.1200\/JCO.1993.11.1.173"},{"issue":"3","key":"1559_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9(3):153\u201366. https:\/\/doi.org\/10.1038\/nrc2602.","journal-title":"Nat Rev Cancer"},{"key":"1559_CR19","doi-asserted-by":"crossref","unstructured":"Gleason CE, Dickson MA, Klein Dooley ME, et al. Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma. Clin Cancer Res. 2024;30(4):703\u2013718. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-2378","DOI":"10.1158\/1078-0432.CCR-23-2378"},{"key":"1559_CR20","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1200\/JCO.22.01285","volume":"41","author":"MM Gounder","year":"2023","unstructured":"Gounder MM, et al. A first-in-human phase I study of milademetan, an MDM2 inhibitor, in patients with advanced liposarcoma, solid tumors, or lymphomas. J Clin Oncol. 2023;41:1714\u201324. https:\/\/doi.org\/10.1200\/JCO.22.01285.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1559_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc3430","volume":"13","author":"M Wade","year":"2013","unstructured":"Wade M, Li YC, Wahl GM. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer. 2013;13(2):83\u201396. https:\/\/doi.org\/10.1038\/nrc3430.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1559_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/jamaoncol.2017.1617","volume":"4","author":"M Toulmonde","year":"2018","unstructured":"Toulmonde M, Penel N, Adam J, et al. Use of PD-1 targeting, macrophage infiltration, and IDO pathway activation in sarcomas: a phase 2 clinical trial. JAMA Oncol. 2018;4(1):93\u20137. https:\/\/doi.org\/10.1001\/jamaoncol.2017.1617.","journal-title":"JAMA Oncol"},{"issue":"7791","key":"1559_CR23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez F, de Reyni\u00e8s A, Keung EZ, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020;577(7791):556\u201360. https:\/\/doi.org\/10.1038\/s41586-019-1906-8.","journal-title":"Nature"},{"key":"1559_CR24","doi-asserted-by":"crossref","unstructured":"Demetri GD, von Mehren M, Jones RL, et al. Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy. J Clin Oncol. 2016;34(8):786\u2013793. https:\/\/doi.org\/10.1200\/JCO.2015.62.4734","DOI":"10.1200\/JCO.2015.62.4734"},{"issue":"10028","key":"1559_CR25","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/S0140-6736(15)01283-0","volume":"387","author":"P Sch\u00f6ffski","year":"2016","unstructured":"Sch\u00f6ffski P, Chawla S, Maki RG, et al. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet. 2016;387(10028):1629\u201337. https:\/\/doi.org\/10.1016\/S0140-6736(15)01283-0.","journal-title":"Lancet"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01559-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01559-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01559-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:14:13Z","timestamp":1786014853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01559-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1559"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01559-y","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Zhongshan Hospital, Fudan University (Approval No. B2022-586R). Written informed consent was obtained from the patient.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"179"}}